Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Similar articles for PubMed (Select 23296188)

1.

Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features.

Gutman BA, Hua X, Rajagopalan P, Chou YY, Wang Y, Yanovsky I, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Apr 15;70:386-401. doi: 10.1016/j.neuroimage.2012.12.052. Epub 2013 Jan 4.

2.

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.

Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Dec;48(4):668-81. doi: 10.1016/j.neuroimage.2009.07.011. Epub 2009 Jul 14.

3.

Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.

Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Feb 1;66:648-61. doi: 10.1016/j.neuroimage.2012.10.086. Epub 2012 Nov 12.

4.

Mapping ventricular expansion onto cortical gray matter in older adults.

Madsen SK, Gutman BA, Joshi SH, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2015 Jan;36 Suppl 1:S32-41. doi: 10.1016/j.neurobiolaging.2014.03.044. Epub 2014 Aug 30.

PMID:
25311280
5.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

6.

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11.

7.

Mapping hippocampal and ventricular change in Alzheimer disease.

Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW.

Neuroimage. 2004 Aug;22(4):1754-66. Erratum in: Neuroimage. 2007 Jul 15;36(4):1397-8.

PMID:
15275931
8.

Empowering imaging biomarkers of Alzheimer's disease.

Gutman BA, Wang Y, Yanovsky I, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S69-80. doi: 10.1016/j.neurobiolaging.2014.05.038. Epub 2014 Aug 27.

PMID:
25260848
9.

Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Sep 15;58(2):469-80. doi: 10.1016/j.neuroimage.2011.05.083. Epub 2011 Jun 16.

PMID:
21718788
10.

Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.

Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 May 15;51(1):63-75. doi: 10.1016/j.neuroimage.2010.01.104. Epub 2010 Feb 6.

11.

Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.

Spulber G, Niskanen E, Macdonald S, Kivipelto M, Padilla DF, Julkunen V, Hallikainen M, Vanninen R, Wahlund LO, Soininen H.

Curr Alzheimer Res. 2012 May;9(4):516-24.

PMID:
22191564
12.

Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.

Westman E, Aguilar C, Muehlboeck JS, Simmons A.

Brain Topogr. 2013 Jan;26(1):9-23. doi: 10.1007/s10548-012-0246-x. Epub 2012 Aug 14.

13.

Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):335-44. doi: 10.1007/s00406-012-0350-7. Epub 2012 Sep 1.

PMID:
22940716
14.

Analysis of spatio-temporal brain imaging patterns by Hidden Markov Models and serial MRI images.

Wang Y, Resnick SM, Davatzikos C; Baltimore Longitudinal Study of Aging; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2014 Sep;35(9):4777-94. doi: 10.1002/hbm.22511. Epub 2014 Apr 7.

PMID:
24706564
15.

Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.

Song X, Mitnitski A, Zhang N, Chen W, Rockwood K; Alzheimer's Disease Neuroimaging Initiative.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):71-8. doi: 10.1136/jnnp-2012-303579. Epub 2012 Nov 2.

PMID:
23123510
16.

An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K; Alzheimer's disease Neuroimaging Initiative.

J Alzheimers Dis. 2011;26 Suppl 3:359-67. doi: 10.3233/JAD-2011-0048.

PMID:
21971475
17.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

18.

Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.

Chou YY, Leporé N, de Zubicaray GI, Carmichael OT, Becker JT, Toga AW, Thompson PM.

Neuroimage. 2008 Apr 1;40(2):615-30. doi: 10.1016/j.neuroimage.2007.11.047. Epub 2007 Dec 8.

19.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
20.

CSF and brain structural imaging markers of the Alzheimer's pathological cascade.

Yang X, Tan MZ, Qiu A.

PLoS One. 2012;7(12):e47406. doi: 10.1371/journal.pone.0047406. Epub 2012 Dec 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk